|
🐜
|
Multiorgan and Renal Tropism of SARS-CoV-2
23 auth.
Victor G. Puelles,
M. Lütgehetmann,
M. Lindenmeyer,
J. Sperhake,
M. N. Wong,
L. Allweiss,
S. Chilla,
A. Heinemann,
Nicola Wanner,
Shuya Liu,
...
Fabian Braun,
Shun Lu,
S. Pfefferle,
A. Schröder,
C. Edler,
O. Gross,
M. Glatzel,
D. Wichmann,
T. Wiech,
S. Kluge,
K. Pueschel,
M. Aepfelbacher,
T. Huber
|
10 |
2020 |
10
🐜
|
|
🐜
|
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
22 auth.
J. Matschke,
M. Lütgehetmann,
C. Hagel,
J. Sperhake,
A. Schröder,
C. Edler,
H. Mushumba,
A. Fitzek,
L. Allweiss,
M. Dandri,
...
Matthias Dottermusch,
A. Heinemann,
S. Pfefferle,
Marius Schwabenland,
Daniel Sumner Magruder,
Stefan Bonn,
M. Prinz,
C. Gerloff,
K. Püschel,
S. Krasemann,
M. Aepfelbacher,
M. Glatzel
|
9 |
2020 |
9
🐜
|
|
🐜
|
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.
10 auth.
L. Belloni,
L. Allweiss,
F. Guerrieri,
N. Pediconi,
T. Volz,
T. Pollicino,
...
J. Petersen,
G. Raimondo,
M. Dandri,
M. Levrero
|
9 |
2012 |
9
🐜
|
|
🐜
|
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.
11 auth.
T. Volz,
L. Allweiss,
Mounira Ben MBarek,
M. Warlich,
A. Lohse,
J. Pollok,
...
A. Alexandrov,
S. Urban,
J. Petersen,
M. Lütgehetmann,
M. Dandri
|
8 |
2013 |
8
🐜
|
|
🐜
|
Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation
12 auth.
A. Lohse,
Rudolf Mancke,
M. Lütgehetmann,
Lida V. Mancke,
T. Volz,
M. Helbig,
...
L. Allweiss,
T. Bornscheuer,
J. Pollok,
J. Petersen,
S. Urban,
M. Dandri
|
7 |
2012 |
7
🐜
|
|
🦁
|
The Role of cccDNA in HBV Maintenance
L. Allweiss,
M. Dandri
|
7 |
2017 |
7
🦁
|
|
🐬
|
Serum HBV pgRNA as a clinical marker for cccDNA activity.
K. Giersch,
L. Allweiss,
T. Volz,
M. Dandri,
M. Lütgehetmann
|
7 |
2017 |
7
🐬
|
|
🦁
|
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
12 auth.
L. Allweiss,
T. Volz,
K. Giersch,
J. Kah,
G. Raffa,
J. Petersen,
...
A. Lohse,
C. Beninati,
T. Pollicino,
S. Urban,
M. Lütgehetmann,
M. Dandri
|
7 |
2017 |
7
🦁
|
|
🐜
|
Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
9 auth.
M. Lütgehetmann,
T. Bornscheuer,
T. Volz,
L. Allweiss,
Jan-Hendrick Bockmann,
J. Pollok,
...
A. Lohse,
J. Petersen,
M. Dandri
|
7 |
2011 |
7
🐜
|
|
🐜
|
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism
16 auth.
N. Oehler,
T. Volz,
O. Bhadra,
J. Kah,
L. Allweiss,
K. Giersch,
J. Bierwolf,
K. Riecken,
J. Pollok,
A. Lohse,
...
B. Fehse,
J. Petersen,
S. Urban,
M. Lütgehetmann,
J. Heeren,
M. Dandri
|
7 |
2014 |
7
🐜
|
|
🦁
|
Experimental in vitro and in vivo models for the study of human hepatitis B virus infection.
L. Allweiss,
M. Dandri
|
6 |
2016 |
6
🦁
|
|
🐜
|
Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
10 auth.
K. Giersch,
L. Allweiss,
T. Volz,
M. Helbig,
J. Bierwolf,
A. Lohse,
...
J. Pollok,
J. Petersen,
M. Dandri,
M. Lütgehetmann
|
6 |
2015 |
6
🐜
|
